ZEISS, Ocumeda, and the Optical Trojan Horse: Omnichannel in MedTech
The €100 Million Bet on Retail Diagnostics Omnichannel in MedTech usually means a half-baked app, an email campaign, or a portal nobody uses. ZEISS changed the script. In March 2025, ZEISS launched its EyeCare Network and quietly took a €10 million stake in Ocumeda, a tele-ophthalmology platform connecting 700 optical stores to 300,000 patients. Retail…
